TABLE 2

Specific inhibitors associated with SLC1 and SLC7 transporters

Human Gene Name	Inhibitor	Formula	IC₅₀	Reference
SLC1A2	WAY-213613	C₁₆H₁₄BrClF₂N₂O₄	0.085 μM	(Simmons et al., 2014)
	DL-TBOA	C₁₁H₁₃NO₅	6 μM	(Pedraz-Cuesta et al., 2015)
	Dihydrokainic acid (DHK)	C₁₀H₁₇NO₄	23 µM(K_i)	(Arriza et al., 1994)
	T3MG	C₆H₁₁NO₄	90 µM	(Eliasof et al., 2001)
SLC1A3	UCPH-101	C₂₇H₂₂N₂O₃	0.66 μM	(Abrahamsen et al., 2013)
	UCPH-102	C₂₁H₁₈N₂O₂	0.42 μM	(Haym et al., 2016)
	DL-TBOA	C₁₁H₁₃NO₅	70 μM	(Shimamoto et al., 1998)
	WAY-213613	C₁₆H₁₃BrF₂N₂O₄	5 μM	(Hashimoto et al., 2018; Tao et al., 2020)
SLC1A5	Lobetyolin	C₂₀H₂₈O₈	N/A	(He et al., 2020)
	V-9302	C₃₄H₃₈N₂O₄	9.6 μM	(Schulte et al., 2018)
	GPNA hydrochloride	C₁₁H₁₄ClN₃O₅	55 μM(K_i)	(Corti et al., 2019)
SLC7A2	Platonin	N/A	N/A	(Chen et al., 2006)
SLC7A5	BCH	C₈H₁₃NO₂	131.5 µM	(Fraga et al., 2002; Kim et al., 2002)
	KMH-233	C₃₂H₂₅N₇O₅	18 μM	(Huttunen et al., 2016)
	GPNA hydrochloride	C₁₁H₁₄ClN₃O₅	250 μM.	(Corti et al., 2019)
	Lats-IN-1	C₁₈H₁₄N₄OS	0.51 μM (EC₅₀)	(Kastan et al., 2021)
	JPH203	C₂₃H₁₉Cl₂N₃O₄	0.14 μM	(Oda et al., 2010)